Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle culture helps study hair growth but has limitations in modeling the full hair cycle.

Latanoprost can make eyelashes longer, thicker, and darker.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Plant roots respond to fungus smells by possibly using certain proteins and a plant hormone to change root growth, but more research is needed.

Environmental factors can cause mutations in skin proteins, leading to skin disorders.

The congress showed advancements in skin hydration, barrier function, and safe, effective new cosmetic formulations.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Men's personal care products often cause allergic skin reactions.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.